Non-Coding RNAs in Health and Disease: Editorial

Catanzaro G
Biomedicines · 2022 · vol. 11(1) · doi:10.3390/biomedicines11010014 · PMID:36672521 · PMC9855804
Other OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-10-14 ⓘ

This editorial introduces non-coding RNAs as the largest component of human transcriptional output, highlighting their significant roles in various health and disease processes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-14 · read from full text ⓘ

This editorial piece serves as an introduction to a special issue on non-coding RNAs, outlining their significant roles in both physiological health and various pathological states. The text does not present original experimental data or specific clinical trials but rather provides a broad overview of the field's current landscape and future directions. It highlights the growing interest in these molecules as potential biomarkers and therapeutic targets across multiple disease categories. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Non-coding RNAs (ncRNAs) represent the largest part of the transcriptional production of the human genome and play key roles in health and disease processes [...].
Full text 521 characters · extracted from epmc-fulltextxml · 5 sections · click to expand

Data

Data sharing not applicable.

Funding

This research received no external funding.

Fn Group

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Conflicts

The author declares no conflict of interest.

Associated Data

Data sharing not applicable.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: epmc-fulltextxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-01T09:25:17.647243+00:00
pubmed
last seen: 2026-10-08T21:38:24.594406+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC